Whereas, the exhausted markers of PD-1 and CTLA-4 were highly expressed in CD8+ T cells treated with IL-35, meaning that multiple cytotoxicity mechanism of CD8+ T cells were applied to therapy HCC (Li et al., 2016). The gene discussed is CD8A; the disease is hepatocellular carcinoma.